254 related articles for article (PubMed ID: 21152079)
1. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
Kim SM; Park YY; Park ES; Cho JY; Izzo JG; Zhang D; Kim SB; Lee JH; Bhutani MS; Swisher SG; Wu X; Coombes KR; Maru D; Wang KK; Buttar NS; Ajani JA; Lee JS
PLoS One; 2010 Nov; 5(11):e15074. PubMed ID: 21152079
[TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG
Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
5. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
[TBL] [Abstract][Full Text] [Related]
6. Profiles of autophagy-related genes in esophageal adenocarcinoma.
Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
Duan L; Cao L; Zhang R; Niu L; Yang W; Feng W; Zhou W; Chen J; Wang X; Li Y; Zhang Y; Liu J; Zhao Q; Fan D; Hong L
Bioengineered; 2021 Dec; 12(1):3434-3454. PubMed ID: 34252349
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
9. A simple two-gene prognostic model for adenocarcinoma of the lung.
Reed CE; Graham A; Hoda RS; Khoor A; Garrett-Mayer E; Wallace MB; Mitas M
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):627-34. PubMed ID: 18329483
[TBL] [Abstract][Full Text] [Related]
10. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
Xu T; Yuan Y; He C; Yang K
Med Sci Monit; 2021 Jan; 27():e927850. PubMed ID: 33510126
[TBL] [Abstract][Full Text] [Related]
11. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
Guo X; Tang Y; Zhu W
BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
14. Association of Biomarkers for Human Papillomavirus With Survival Among Adults With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma.
Rajendra S; Sharma P; Gautam SD; Saxena M; Kapur A; Sharma P; Merrett N; Yang T; Santos LD; Pavey D; Sharaiha O; McKay O; Dixson H; Xuan W
JAMA Netw Open; 2020 Feb; 3(2):e1921189. PubMed ID: 32058552
[TBL] [Abstract][Full Text] [Related]
15. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
16. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.
Loeser H; Kraemer M; Gebauer F; Bruns C; Schröder W; Zander T; Alakus H; Hoelscher A; Buettner R; Lohneis P; Quaas A
J Immunol Res; 2020; 2020():2862647. PubMed ID: 33029538
[TBL] [Abstract][Full Text] [Related]
20. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
Lan T; Liu W; Lu Y; Luo H
Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]